Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Nalidixic acid
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Generic Mictral granules 7g sachets
0501120N0AAACAC
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
Mictral granules 7g sachets
0501120N0BDAAAC
|
Mictral | Nalidixic acid | Infections | No data available |
|
Nalidixic acid 300mg/5ml oral suspension
0501120N0AAAAAA
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
Nalidixic acid 300mg/5ml oral suspension sugar free
0501120N0AAAFAF
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
Nalidixic acid 500mg tablets
0501120N0AAABAB
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
Negram 300mg/5ml oral suspension
0501120N0BBABAF
|
Negram | Nalidixic acid | Infections | No data available |
|
Negram 500mg tablets
0501120N0BBAAAB
|
Negram | Nalidixic acid | Infections | No data available |
|
Uriben 300mg/5ml oral suspension
0501120N0BCAAAA
|
Uriben | Nalidixic acid | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.